McClatchey A I, McKenna-Yasek D, Cros D, Worthen H G, Kuncl R W, DeSilva S M, Cornblath D R, Gusella J F, Brown R H
Molecular Neurogenetics Laboratory, Massachusetts General Hospital, Boston.
Nat Genet. 1992 Oct;2(2):148-52. doi: 10.1038/ng1092-148.
Mutations in the skeletal muscle sodium channel gene (SCN4A) have been described in paramyotonia congenita (PMC) and hyperkalaemic periodic paralysis (HPP). We have found two mutations in SCN4A which affect regions of the sodium channel not previously associated with a disease phenotype. Furthermore, affected family members display an unusual mixture of clinical features reminiscent of PMC, HPP and of a third disorder, myotonia congenita (MC). The highly variable individual expression of these symptoms, including in some cases apparent non-penetrance, implies the existence of modifying factors. Mutations in SCN4A can produce a broad range of phenotypes in muscle diseases characterized by episodic abnormalities of membrane excitability.
骨骼肌钠通道基因(SCN4A)的突变已在先天性副肌强直(PMC)和高钾性周期性麻痹(HPP)中被描述。我们在SCN4A中发现了两个突变,这些突变影响了钠通道中以前未与疾病表型相关联的区域。此外,受影响的家庭成员表现出一种不寻常的临床特征组合,让人联想到PMC、HPP以及第三种疾病——先天性肌强直(MC)。这些症状在个体中的高度可变表达,包括在某些情况下明显的外显不全,意味着存在修饰因子。SCN4A中的突变可在以膜兴奋性发作性异常为特征的肌肉疾病中产生广泛的表型。